Thx Paul. I hope this part is from a month and a h
Post# of 36503
![Avatar](/images/ProfileImages/1715814134_58173_seamless-frog-green-pond-1131954.jpg)
“ To date, Generex has identified viral epitopes through computer vaccinology algorithms, and manufactured those peptide sequences with the Ii-Key moiety for testing in immunological screening program using convalescent blood samples from patients who have recovered from COVID-19. The immunological blood screening program is scheduled to begin shortly. ”
Because later Joe says...
“ We have initiated the blood screening program using convalescent blood and serum for COVID-19 recovered patients to select Ii-Key-SARS-CoV-2 epitopes that will comprise the final vaccine formulation,”
So again, does initiating the program mean they testing on blood is done, or ready to start?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)